Refined mapping of the region of loss of heterozygosity on the long arm of chromosome 7 in human breast cancer defines the location of a second tumor suppressor gene at 7q22 in the region of the CUTL1 gene

Oncogene

Volumn 18, Issue 11, 1999, Pages 2015-2021

  Zeng, Wendy Rong ^a   Watson, Peter ^b   Lin, Jenny ^a   Jothy, Serge ^c   Lidereau, Rosette ^d   Park, Morag ^a   Nepveu, Alain ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d CENTRE RENÉ HUGUENIN   (France)

Author keywords

Breast cancer; Chromosome 7q22; CUTL1; Human Cut homebox gene; Loss of heterozygosity; Tumor suppressor gene

Indexed keywords

VIRUS LARGE T ANTIGEN;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; BREAST CANCER; CHROMOSOME 7Q; GENE DELETION; GENE LOCATION; GENE MAPPING; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; POLYOMA VIRUS; PRIORITY JOURNAL; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE; TUMOR VOLUME; UTERUS MYOMA;

MUS MUSCULUS; POLYOMAVIRUS;

EID: 0033580423     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202519     Document Type: Article

References (48)

1. Andres V, Nadal-Ginard B and Mahdavi V. (1992). Dev., 116, 321-334.
2. Berkerkarauzum S, Luleci G, Ozbilim G, Erdogan A, Kuzucu A et al. (1998). Cancer Gene. Cytogen., 100, 114-123.
3. Bièche I, Champeme MH, Matifas F, Hacene K, Callahan R et al. (1992). Lancet, 339, 139-143.
4. Bièche I, Khodja A, Driouch K and Lidereau R. (1997). Clin. Cancer Res., 3, 1009-1016.
5. Bièche I and Lidereau R. (1995). Genes, Chrom. Cancer, 14, 227-251.
6. Callahan R, Cropp C, Merlo GR, Diella F, Venesio T et al. (1993). Clinica Chimica Acta, 217, 63-73.
7. Champeme MH, Bieche I, Beuzelin M and Lidereau R. (1995). Genes Chrom. Cancer, 12, 304-306.
8. Coqueret O, Bérubé G and Nepveu A. (1998). EMBO J., 17, 4680-4694.
9. Dave BJ, Hopwood VL, King TM. Jiang H, Spitz MR et al. (1995). Cancer Epidem. Biomarkers Prev. 4, 743-749.
10. Deng G, Chen LC, Schott DR, Thor A, Bhargava V et al. (1994). Cancer Res., 54, 499-505.
11. Devilee P, Hermans J, Eyfjord J, Boorresen AL, Liderau R et al. (1997). Genes Chrom. Cancer, 18, 193-199.
12. Dufort D and Nepveu A. (1994). Mol. Cell. Biol., 14, 4251-4257.
13. Fischer K. Brown J, Scherer SW, Schramm P, Stewart J et al. (1998). Recent Res. Cancer Res., 144, 46-52.
14. Haber D and Harlow E. (1997). Nature Genet., 16, 320-322.
15. Harada R, Dufort D, Denis-Larose C and Nepveu A. (1994). J. Biol. Chem., 269, 2062-2067.
16. Harris JR. Lippman ME, Veronesi U and Willett W. (1992). N. Engl. J. Med., 327, 319-328.
17. Ishwad CS, Ferrell RE, Hanley K, Davare J, Meloni AM et al. (1997). Genes Chrom. Cancer, 19, 156-160.
18. Isobe M, Emanuel BS, Givol D, Oren M and Croce CM. (1986). Nature, 320, 84-85.
19. Kerangueven F, Noguchi T, Coulier F, Allione F, Wargniez V et al. (1997). Cancer Res., 57, 5469-5474.
20. Kristjansson AK, Eiriksdottir G, Ragnarsson G, Sigurdsson A, Gudmundsson J et al. (1997). Anticancer Res., 17, 93-98.
21. Larsson C, Bystrom C, Skoog L, Rotstein S and Nordenskjold M. (1990). Genes Chrom. Cancer, 2, 191-197.
22. Lin JC, Scherer SW, Tougas L, Traverso G, Tsui LC et al. (1996). Oncogene, 13, 2001-2008.
23. Lundgren R. (1991). Scand. J. Urol. Nephrol., 136, 1-35.
24. Lundgren R, Mandahl N, Heim S, Limon J, Henrikson H et al. (1992). Genes Chrom. Cancer, 4, 16-24.
25. Mailly F, Berube G, Harada R, Mao PL, Phillips S et al. (1996). Mol. Cell. Biol., 16, 5346-5357.
26. Mann HB and Whitney DR. (1947). Ann. Mathemat. Stat., 18, 50-60.
27. McBride OW, Merry D and Givol D. (1986). Proc. Natl. Acad. Sci. USA, 83, 130-134.
28. Mertens F, Johansson B, Hoglund M and Mitelman F. (1997). Cancer Res., 57, 2765-2780.
29. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K et al. (1994). Science, 266, 66-71.
30. Miller C, Mohandas T, Wolf D, Prokocimer M, Rotter V et al. (1986). Nature, 319, 783-784.
31. Neufeld EJ, Skalnik DG, Lievens PM and Orkin SH. (1992). Nature Genet., 1, 50-55.
32. Ozïsik YY, Meloni AM, Surti U and Sandberg AA. (1993). Cancer Genetics & Cytogenetics 71, 1-6.
33. Quaggin SE, Vandenheuvel GB, Golden K, Bodmer R and Igarashi P. (1996). J. Biol. Chem., 271, 22624-22634.
34. Sargent MS, Weremowicz S, Rein MS and Morton CC. (1994). Cancer Genetics & Cytogenetics 77, 65-68.
35. Sato T, Tanigami A, Yamakawa K, Akiyama F, Kasumi F et al. (1990). Cancer Res., 50, 7184-7189.
36. Skalnik DG, Strauss EC and Orkin SH. (1991). J. Biol. Chem., 266, 16736-16744.
37. Solinas-Toldo S, Wallrapp C, Muller-Pillasch F, Bentz M, Gress T et al. (1996). Cancer Res., 56, 3803-3807.
38. Storto PD, Saidman SL, Demetris AJ, Letessier E, Whiteside TL et al. (1990). Genes Chrom. Cancer 2, 300-310.
39. Tougas L, Halwani F, Tremblay G, Sampalis J, Lin J et al. £il. (1996). Clin. Investig. Med. Medecine Clinique et Experimentale, 19, 222-230.
40. Valarche I, Tissier-Seta JP, Hirsch MR, Martinez S, Goridis C et al. (1993). Development, 119, 881-896.
41. Watson PH, Safneck JR, Le K, Dubik D and Shiu RP. (1993). J. Natl. Cancer Inst. 85, 902-907.
42. Watson PH, Snell L and Parisien M. (1996). Cmaj. 155, 281-283.
43. Webster MA, Martinsoudant N, Nepveu A, Cardiff RD and Muller WJ. (1998). Oncogene, 16, 1963 - 1972.
44. Wooster R, Bignell G, Lancaster J, Swift S, Seal S et al. (1995). Nature, 378, 789-792.
45. Xing YP, Powell WL and Morton CC. (1997). Cancer Genetics & Cytogenetics 98, 69-74.
46. Yoon SO and Chikaraishi DM. (1994). J. Biol. Chem., 269, 18453-18462.
47. Zeng WR, Scherer SW, Koutsilieris M, Huizenga JJ, Filteau F et al. (1997). Oncogene, 14, 2355-2365.
48. Zenklusen JC, Bieche I, Lidereau R and Conti CJ. (1994). Proc. Natl. Acad. Sci. USA, 91, 12155-12158.